
License agreements for COVID-19 therapeutics / World Health Organization. Regional Office for South-East Asia
Tác giả : World Health Organization. Regional Office for South-East Asia
Nhà xuất bản : World Health Organization. Regional Office for South-East Asia
Năm xuất bản : 2022
Chủ đề : 1. COVID-19. 2. Publications.
Thông tin chi tiết
Tóm tắt : | "License agreements for COVID-19 therapeutics” is developed to give information on licensesconcluded for therapeutics in the treatment of COVID-19. The voluntary license agreementsunder the aegis of Medicines Patent Pool (MPP) serve to encourage production of medicines incountries by pharmaceutical companies.The MPP and WHO have an official working relationship for collaborating on a wide range ofissues including prioritizing products for in-licensing, quality assurance and patent transparency.The information in the brochure will serve as a quick guide for policy decision-making forintroduction of therapeutics in the treatment of COVID 19. It is useful for ministry officials, healthprofessionals and pharmaceutical partners in the country |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/362114 |